|
Characteristics
|
LC
|
HCC
|
P
|
|---|
|
AFP (ng/mL)
|
6.2 ± 15.8
|
507.8 ± 1565.9
|
< 0.001*
|
|
AFP ≥ 20 ng/mL
|
2 (6.67)
|
12 (37.5)
|
-
|
|
AFP ≥ 200 ng/mL
|
0 (0.0)
|
6 (18.8)
|
-
|
|
ALT (UI/mL)
|
35.4 ± 41.3
|
39.5 ± 43.2
|
0.698
|
|
AST (UI/mL)
|
37.3 ± 22.4
|
45.3 ± 43.0
|
0.746
|
|
ALP (U/L)
|
86.6 ± 51.6
|
119.2 ± 70.1
|
0.022*
|
|
GGT (U/L)
|
64.2 ± 98.2
|
108.1 ± 121.0
|
0.045*
|
|
Total bilirubin (mg/dL)
|
0.7 ± 0.3
|
1.1 ± 1.4
|
0.481
|
|
Albumin (g/dL)
|
4.7 ± 0.4
|
4.4 ± 0.8
|
0.117
|
|
Platelets (*1,000/mm3)
|
155.8 ± 89.5
|
156.0 ± 86.3
|
0.910
|
|
PT (seconds)
|
14.1 ± 2.1
|
13.2 ± 1.7
|
0.013*
|
|
Child-Pugh score
| | | |
|
A
|
30 (53.6)
|
26 (46.4)
|
0.030*
|
|
B or C
|
0 (0.0)
|
6 (100.0)
|
|
Total cholesterol (mg/dL)
|
179.4 ± 38.1
|
172.8 ± 41.0
|
0.511
|
|
Tumor size (mm)
|
-
|
37.0 ± 23.0
|
-
|
|
BCLC stage
| | | |
|
0
|
-
|
5 (15.6)
|
-
|
|
A
|
-
|
14 (43.8)
|
-
|
|
B
|
-
|
10 (31.2)
|
-
|
|
C
|
-
|
1 (3.1)
|
-
|
|
D
|
-
|
2 (6.3)
|
-
|
- Results are presented as number and percentage for categorical variables and as mean value and standard deviation for continuous variables. LC liver cirrhosis, HCC hepatocellular carcinoma, AFP alpha-fetoprotein, ALT alanine aminotransferase, AST aspartate aminotransferase, ALP alkaline phosphatase, GGT gamma glutamyl transpeptidase, PT prothrombin time, BCLC Barcelona-Clinic Liver Cancer. *Significant at 0.05
